Vernon Knight

7.3k total citations
164 papers, 5.6k citations indexed

About

Vernon Knight is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vernon Knight has authored 164 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Epidemiology, 45 papers in Infectious Diseases and 38 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vernon Knight's work include Respiratory viral infections research (36 papers), Influenza Virus Research Studies (24 papers) and Inhalation and Respiratory Drug Delivery (24 papers). Vernon Knight is often cited by papers focused on Respiratory viral infections research (36 papers), Influenza Virus Research Studies (24 papers) and Inhalation and Respiratory Drug Delivery (24 papers). Vernon Knight collaborates with scholars based in United States, Canada and United Kingdom. Vernon Knight's co-authors include Brian E. Gilbert, J. Clifford Waldrep, Nadezhda V. Koshkina, R. B. Couch, R. Gordon Douglas, Philip R. Wyde, Peter J. Gerone, T. R. Cate, J. A. Kasel and S Z Wilson and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Vernon Knight

160 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vernon Knight United States 43 2.0k 1.6k 1.3k 1.1k 514 164 5.6k
Brian E. Gilbert United States 40 1.8k 0.9× 1.1k 0.7× 1.0k 0.8× 1.2k 1.0× 235 0.5× 118 4.7k
J. Thomas LaMont United States 40 1.7k 0.8× 652 0.4× 3.0k 2.3× 1.6k 1.4× 274 0.5× 103 6.5k
Donald N. Buell United States 43 2.9k 1.4× 654 0.4× 3.7k 2.8× 1.3k 1.2× 283 0.6× 73 7.2k
Robert L. Hunter United States 42 2.0k 1.0× 458 0.3× 2.2k 1.7× 1.5k 1.4× 209 0.4× 197 6.9k
Reuben Ramphal United States 56 1.6k 0.8× 1.7k 1.1× 706 0.5× 3.5k 3.1× 1.4k 2.6× 134 8.6k
Piera Valenti Italy 49 796 0.4× 718 0.5× 1.5k 1.1× 1.7k 1.5× 682 1.3× 207 7.2k
Arne Forsgren Sweden 48 2.7k 1.4× 745 0.5× 1.5k 1.1× 2.3k 2.1× 408 0.8× 239 8.5k
Martina Ulrich Germany 38 1.6k 0.8× 1.9k 1.2× 914 0.7× 2.9k 2.6× 445 0.9× 114 6.8k
S. Groth Denmark 35 1.2k 0.6× 1.2k 0.8× 496 0.4× 1.7k 1.5× 395 0.8× 140 6.2k
Morton N. Swartz United States 43 2.3k 1.1× 419 0.3× 2.0k 1.5× 1.7k 1.5× 542 1.1× 89 8.7k

Countries citing papers authored by Vernon Knight

Since Specialization
Citations

This map shows the geographic impact of Vernon Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vernon Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vernon Knight more than expected).

Fields of papers citing papers by Vernon Knight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vernon Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vernon Knight. The network helps show where Vernon Knight may publish in the future.

Co-authorship network of co-authors of Vernon Knight

This figure shows the co-authorship network connecting the top 25 collaborators of Vernon Knight. A scholar is included among the top collaborators of Vernon Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vernon Knight. Vernon Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hicks, Allison L., et al.. (2024). DECREASED ALLERGENIC PROTEIN CONTENT OF HARD-BOILED EGGS VS SCRAMBLED: WHEN FOOD SCIENCE MEETS CLINICAL PRACTICE. Annals of Allergy Asthma & Immunology. 133(6). S70–S71. 1 indexed citations
2.
Knight, Vernon, Peter J. Gerone, Robert B. Couch, et al.. (2015). Studies in Volunteers with Respiratory Viral Agents1. American Review of Respiratory Disease.
3.
Koshkina, Nadezhda V., Eva Golunski, Luz Roberts, Brian E. Gilbert, & Vernon Knight. (2004). Cyclosporin A Aerosol Improves the Anticancer Effect of Paclitaxel Aerosol in Mice. Journal of Aerosol Medicine. 17(1). 7–14. 51 indexed citations
4.
Lawson, Karla A., K. C. Anderson, Marla Simmons-Menchaca, et al.. (2004). Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis. Cancer Chemotherapy and Pharmacology. 54(5). 421–431. 54 indexed citations
5.
Koshkina, Nadezhda V., J. Clifford Waldrep, & Vernon Knight. (2003). Camptothecins and Lung Cancer: Improved Delivery Systems by Aerosol. Current Cancer Drug Targets. 3(4). 251–264. 27 indexed citations
6.
7.
Gautam, Ajay Kumar, J. Clifford Waldrep, Charles L. Densmore, et al.. (2002). Growth inhibition of established B16-F10 lung metastases by sequential aerosol delivery of p53 gene and 9-nitrocamptothecin. Gene Therapy. 9(5). 353–357. 30 indexed citations
8.
Koshkina, Nadezhda V., Vernon Knight, Brian E. Gilbert, et al.. (2001). Improved respiratory delivery of the anticancer drugs, camptothecin and paclitaxel, with 5% CO 2 -enriched air: pharmacokinetic studies. Cancer Chemotherapy and Pharmacology. 47(5). 451–456. 55 indexed citations
9.
Koshkina, Nadezhda V., et al.. (2000). 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.. PubMed. 6(7). 2876–80. 85 indexed citations
10.
Densmore, Charles L., Frank M. Orson, Bo Xu, et al.. (2000). Aerosol Delivery of Robust Polyethyleneimine– DNA Complexes for Gene Therapy and Genetic Immunization. Molecular Therapy. 1(2). 180–188. 140 indexed citations
11.
Verschraegen, Claire F., Kurt A. Jaeckle, Beppino C. Giovanella, Vernon Knight, & Brian E. Gilbert. (2000). Alternative Administration of Camptothecin Analogues. Annals of the New York Academy of Sciences. 922(1). 237–246. 14 indexed citations
12.
Gilbert, Brian E., Francisco Alvarez, J. Clifford Waldrep, et al.. (1997). Tolerance of Volunteers to Cyclosporine A-dilauroylphosphatidylcholine Liposome Aerosol. American Journal of Respiratory and Critical Care Medicine. 156(6). 1789–1793. 39 indexed citations
13.
Waldrep, J. Clifford, et al.. (1994). Nebulized Glucocorticoids in Liposomes: Aerosol Characteristics and Human Dose Estimates. Journal of Aerosol Medicine. 7(2). 135–145. 30 indexed citations
14.
Gilbert, Brian E., Philip R. Wyde, Mark Ambrose, Samuel Z. Wilson, & Vernon Knight. (1992). Further studies with short duration ribavirin aerosol for the treatment of influenza virus infection in mice and respiratory syncytial virus infection in cotton rats. Antiviral Research. 17(1). 33–42. 29 indexed citations
15.
Garçon, Nathalie, et al.. (1989). Liposomes of enviroxime and phosphatidylcholine: Definition of the drug-phospholipid interactions. Antiviral Research. 11(2). 89–98. 5 indexed citations
16.
Wyde, Philip R., et al.. (1984). Efficacy of Aerosolized Recombinant Interferons Against Vesicular Stomatitis Virus-Induced Lung Infection in Cotton Rats. Journal of Interferon Research. 4(4). 449–459. 7 indexed citations
17.
Ga, Galegov, et al.. (1981). Investigation of the combined effect of rimantadine (amantadine) and ribavirin on experimental influenza infection.. Problems of Virology. 697–701. 1 indexed citations
18.
Atkinson, Arthur J., et al.. (1967). Evaluation of B.663 in human leprosy.. PubMed. 35(2). 119–27. 26 indexed citations
19.
Knight, Vernon, et al.. (1964). THROMBOCYTOPENIA IN VIVAX MALARIA. The Lancet. 283(7327). 240–241. 37 indexed citations
20.
Knight, Vernon, et al.. (1952). Methenamine mandelate: antimicrobial activity, absorption and excretion.. PubMed. 2(12). 615–35. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian E. Gilbert Breakdown of academic impact, for papers by J. Thomas LaMont Breakdown of academic impact, for papers by Donald N. Buell Breakdown of academic impact, for papers by Robert L. Hunter Breakdown of academic impact, for papers by Reuben Ramphal Breakdown of academic impact, for papers by Piera Valenti Breakdown of academic impact, for papers by Arne Forsgren Breakdown of academic impact, for papers by Martina Ulrich Breakdown of academic impact, for papers by S. Groth Breakdown of academic impact, for papers by Morton N. Swartz
Rankless by CCL
2026